An Act to amend the Patent Act (drugs for international humanitarian purposes)

This bill is from the 41st Parliament, 1st session, which ended in September 2013.

Sponsor

Hélène Laverdière  NDP

Introduced as a private member’s bill. (These don’t often become law.)

Status

Defeated, as of Nov. 28, 2012
(This bill did not become law.)

Summary

This is from the published bill.

This enactment amends the Patent Act to make it easier to manufacture and export pharmaceutical products to address public health problems afflicting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other epidemics.

Similar bills

S-208 (41st Parliament, 1st session) An Act to amend the Patent Act and the Food and Drugs Act (drugs for international humanitarian purposes)
C-393 (40th Parliament, 3rd session) An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act
C-393 (40th Parliament, 2nd session) An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act
S-232 (40th Parliament, 2nd session) An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from Parliament. You can also read the full text of the bill.

Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other C-398s:

C-398 (2024) An Act to amend the National Housing Strategy Act
C-398 (2018) An Act to amend the Immigration and Refugee Protection Act (medical inadmissibility — excessive demand)
C-398 (2010) An Act to amend the Telecommunications Act (Internet neutrality)
C-398 (2009) An Act to amend the Telecommunications Act (Internet neutrality)

Votes

Nov. 28, 2012 Failed That the Bill be now read a second time and referred to the Standing Committee on Foreign Affairs and International Development.

Patent ActPrivate Members' Business

November 21st, 2012 / 7:40 p.m.

Some hon. members

Nay.

Patent ActPrivate Members' Business

November 21st, 2012 / 7:40 p.m.

The Deputy Speaker

In my opinion, the yeas have it.

And five or more members having risen:

Pursuant to Standing Order 93, the division stands deferred until Wednesday, November 28, immediately before the time provided for private members' business.

The House resumed from November 21 consideration of the motion that Bill C-398, An Act to amend the Patent Act (drugs for international humanitarian purposes), be read the second time and referred to a committee.

Patent ActPrivate Members' Business

November 28th, 2012 / 5:30 p.m.

The Deputy Speaker Joe Comartin

It being 5:30 p.m., the House will now proceed to the taking of the deferred recorded division on the motion at second reading stage of Bill C-398 under private members' business.

Call in the members.

(The House divided on the motion, which was negatived on the following division:)

Vote #515

Patent ActPrivate Members' Business

November 28th, 2012 / 6:10 p.m.

The Speaker Andrew Scheer

I declare the motion defeated.